AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$12.75
−$0.66 (−4.89%) 12:00 PM ET
Prev closePrevC$13.40
OpenOpen$12.71
Day highHigh$12.90
Day lowLow$12.42
VolumeVol8,437,708
Avg volAvgVol21,833,513
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$8.94B
EV/Sales
0.64
P/E ratio
8.86
FY Revenue
$17.81B
EPS
1.51
Gross Margin
49.54%
Div yield
5.41%
Sector
Materials
AI report sections
MIXED
CTVA
Corteva, Inc.
CTVA closed at $89.97 after advancing across the one-, three-, and six-month periods, with price positioned near its 52-week high and above its short- and medium-term averages, indicating broad upward price momentum. The advance is accompanied by an elevated RSI and a close marginally below VWAP, which indicate near-term extension and intraday friction. Fundamentally, positive operating margins and modest leverage contrast with declining earnings, weakening operating cash flow, and valuation multiples that appear elevated relative to current cash generation.
AI summarized at 8:24 PM ET, 2026-09-02
AI summary scores
INTRADAY:66SWING:70LONG:42
Volume vs average
Intraday (cumulative)
+214% (Above avg)
Vol/Avg: 3.14×
RSI
9.27(Oversold)
Oversold (<30)
0255075100
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.00 Signal: 0.00
Short-Term
-2.98 (Weak)
MACD: -18.89 Signal: -15.91
Long-Term
-5.13 (Weak)
MACD: -21.54 Signal: -16.41
Intraday trend score
50.55
LOW41.02HIGH53.52
Latest news
CTVA•12 articles•Positive: 9Neutral: 1Negative: 2
NeutralZacks Investment Research• Na
Is Mission Produce's Peru Business Ready to Drive Growth?
Mission Produce expects Peru's fiscal 2026 exportable avocado output to reach 120-130 million pounds, up from 105 million pounds, with Q4 adjusted EBITDA of $52-$55 million. The company benefits from improved farm productivity and expanded distribution, though lower avocado prices remain a headwind. Corteva and Dole are also positioning themselves to capitalize on growing agricultural demand in Latin America, though both face pricing pressures and market challenges.
Company is well-positioned to benefit from growing demand for crop-protection solutions in Latin America and has a focused portfolio post-seed business separation. However, competitive pricing pressures and farm economics fluctuations present offsetting headwinds.
PositiveZacks Investment Research• Na
AgTech & Food Innovation Stocks Driving Smarter Food Systems
The agricultural technology and food innovation sector is being transformed by the need for efficient food production and changing consumer preferences. Companies are advancing crop science, digital farming, automation, and biological solutions to improve productivity. Key players like Corteva, Tyson Foods, Trimble, Ingredion, and Deere & Company are leading innovation across the value chain, from precision farming technologies to convenient food products and AI-powered formulation platforms.
Well-aligned with AgTech trends through its crop-protection portfolio and focus on differentiated agricultural technologies that improve farmer productivity.
NegativeZacks Investment Research• Na
Archer Daniels Surpasses 50-Day SMA: Time to Buy or Stay Cautious?
Archer Daniels Midland (ADM) has broken above its 50-day simple moving average, signaling renewed technical strength. The company raised its 2026 adjusted EPS guidance to $5.15-$5.60 from $4.15-$4.70, driven by improved crushing and ethanol economics, stronger biofuels backdrop, and accelerating Nutrition segment momentum. ADM has outperformed peers and the broader market with a 43% year-to-date gain, though it trades at a premium valuation of 14.61X forward P/E compared to the industry average of 8.06X.
Stock has plummeted 79.2% year-to-date, significantly underperforming ADM and the broader market, indicating substantial weakness in the agriculture sector.
PositiveThe Motley Fool• Josh Kohn-Lindquist
Stock Market Today, Oct. 6: Corteva Rallies 12% on Analyst Upgrade Following Spin Off
Corteva (CTVA) surged 12% following a JPMorgan upgrade to Overweight with a $19 price target, implying 37% upside. The rally was fueled by the company's separation from Vylor and its inclusion in the S&P MidCap 400. Trading at 5.7x 2027 EBITDA, Corteva is positioned as a deep-value opportunity in crop protection, though legal liabilities from PFAS/PFOA concerns remain a risk factor.
JPMorgan upgraded the stock to Overweight with a $19 price target (37% upside), stock rallied 12%, and the company is positioned as a pure-play crop protection provider with attractive valuation at 5.7x 2027 EBITDA. However, sentiment is tempered by significant legal liabilities from PFAS/PFOA inheritance.
PositiveThe Motley Fool• Scott Levine
Why Corteva Stock Is Rocketing Higher Today
Corteva stock surged 12.99% following JPMorgan's upgrade to overweight with a $19 price target, implying 53.3% upside from the previous closing price of $12.39. The upgrade comes after Corteva's October spinoff of its advanced seed and genetics business, with JPMorgan believing the company is now undervalued. The crop protection segment has shown strong growth, with over $1 billion in sales increases and 250 basis points of margin expansion from 2020-2025.
JPMorgan upgraded the stock from neutral to overweight with a $19 price target representing 53.3% upside potential. The upgrade is based on the company being undervalued following its spinoff and strong historical performance in its crop protection business with significant sales and margin growth.
PositiveZacks Investment Research• Na
What's Powering Growth in Mission Produce's Marketing Unit?
Mission Produce's Marketing and Distribution segment saw Q3 fiscal 2026 sales rise to $414.3 million from $344.1 million, driven by 38% volume growth in avocados following the Calavo acquisition and improved sourcing flexibility across Mexico, California, and Peru. The company gained approximately 60 basis points in U.S. retail market share year-to-date and expects further growth opportunities through 2030 via cross-selling and expanded capacity rather than aggressive acquisitions.
AVOCTVADOLEavocado volumesCalavo acquisitionsourcing flexibilitymarket share gainsfresh produce demand
Sentiment note
Benefits from solid demand for differentiated seed technology, disciplined pricing, productivity gains, and portfolio improvement initiatives supporting profitability despite some volume pressures.
PositiveZacks Investment Research• Na
Constellation Brands' Pre-Q2 Earnings: Is It Poised to Beat Estimates?
Constellation Brands is expected to report 3.6% revenue growth but flat EPS in Q2 FY2027. While the beer business benefits from premiumization and Mexico capacity investments, the company faces headwinds from weak Wine & Spirits sales, uneven consumer demand, and inflation-driven cost pressures. The stock trades at an attractive valuation but carries a negative earnings surprise indicator.
CTVA has a notably strong Earnings ESP of +19.35% and Zacks Rank #3 (Hold), indicating high probability of earnings beat. Despite expected EPS decline, the company has a strong track record with 21.9% average trailing four-quarter earnings surprise.
PositiveZacks Investment Research• Na
Mission Produce's Blueberry Business: A Hidden Opportunity?
Mission Produce's blueberry segment is expanding with Q3 sales rising to $5.4M from $4.5M year-over-year, though currently unprofitable due to seasonality. The company expects stronger Q4 performance as the seasonal ramp begins. Meanwhile, Corteva benefits from innovation-driven agricultural demand, while Dole faces margin pressures from elevated input costs and supply chain challenges, partially offset by strong diversified produce performance.
Strong positioning in agricultural innovation with advanced seeds, crop protection products, and biological offerings. Sustained demand for productivity solutions and continued R&D investment support long-term growth prospects across global markets.
PositiveZacks Investment Research• Zacks Investment Research
Zacks Industry Outlook Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole
The Agriculture-Operations industry is positioned to benefit from long-term structural growth drivers including innovation in seeds, crop inputs, and supply-chain technologies, along with rising consumer demand for healthier and sustainably produced food. However, the sector faces persistent headwinds from volatile commodity prices, elevated input and labor costs, and trade uncertainties that are pressuring margins. Five industry leaders are highlighted as well-positioned to capitalize on evolving global food and agriculture trends.
Zacks Rank #3 (Hold) with industry-leading product pipeline and innovation focus. Expected 11.4% earnings growth for 2026, strong price execution in seeds, and 21.9% average earnings surprise in trailing four quarters indicate solid performance.
PositiveZacks Investment Research• Na
Will Higher Peru Output Strengthen Mission Produce's Outlook?
Mission Produce (AVO) expects record Peru avocado production of 120-130 million pounds in fiscal 2026, up 20% year-over-year, which should improve margins in the second half as supply shifts from Mexico toward Peru and California. The company forecasts second-half adjusted EBITDA of $84-$88 million, though third-quarter prices are expected to decline 15% year-over-year due to increased industry supply.
Strong adoption of newer Crop Protection products, healthy underlying demand in Brazil with expanding acreage and increased disease/pest pressure supporting product usage.
NegativeZacks Investment Research• Na
DOLE or CTVA: Which Is the Better Value Stock Right Now?
In a comparison of two agriculture-operations stocks, Dole (DOLE) emerges as the superior value investment option compared to Corteva, Inc. (CTVA). Dole holds a Zacks Rank of #2 (Buy) versus Corteva's #3 (Hold), and demonstrates significantly more attractive valuation metrics including a forward P/E of 9.81 versus 22.53, a PEG ratio of 1.44 versus 2.58, and a P/B ratio of 0.91 versus 2.2. Dole received a Value grade of A while Corteva received a D.
Corteva has a lower Zacks Rank (#3 Hold), significantly higher valuation multiples (P/E of 22.53, PEG of 2.58, P/B of 2.2), and a D-grade Value score, indicating it is less attractive for value-focused investors compared to Dole.
PositiveGlobeNewswire Inc.• Sns Insider
Bioherbicides Market Size to Surpass USD 16.17 Billion by 2035; Growth Driven by Rising Organic Farming Adoption and Regulatory Support | SNS Insider
The global bioherbicides market is projected to grow from USD 3.91 billion in 2025 to USD 16.17 billion by 2035, at a CAGR of 15.26%. Growth is driven by increasing organic farming adoption, regulatory support for low-risk biopesticides, and advancements in microbial herbicides and seed treatment technologies. North America dominates the market with the U.S. accounting for 78.70% of regional revenue, while Asia Pacific is the fastest-growing region.
Company commercially released Forcivo biofungicide in international markets in 2024, demonstrating active product development and market expansion in the growing bioherbicides sector.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal